Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...

FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more ...

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

The U.S. FDA approved Gilead Sciences' lenacapavir injection to prevent HIV in adults and adolescents. Marketed as Yeztugo, ...